CD79B and B-cell non-Hodgkin lymphoma: In our study focusing on CD79b expression, we examined 127 lymph node samples from pts with histological diagnosis of aggressive B-cell lymphomas; furthermore, we included 16 cases of benign reactive hyperplasia (BRH) as controls.